logo
Twitter
Discord
Email
logo
Lifeway Foods, Inc.

Lifeway Foods, Inc.

NASDAQ•LWAY
CEO: Ms. Julie Smolyansky
Sector: Consumer Defensive
Industry: Packaged Foods
Listing Date: 1988-12-29
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, GlenOaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. Lifeway Foods, Inc. was incorporated in 1986 and is based in Morton Grove, Illinois.
Contact Information
6431 West Oakton Street, Morton Grove, IL, 60053, United States
847-967-1010
lifewaykefir.com
Market Cap
$335.03M
P/E (TTM)
30.0
11.6
Dividend Yield
--
52W High
$34.20
52W Low
$19.50
52W Range
17%
Rank33Top 25.7%
4.8
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 4.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$57.14M+23.97%
4-Quarter Trend

EPS

$0.23+15.00%
4-Quarter Trend

FCF

$1.77M-70.06%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Nine Month Sales Growth Net sales reached $157,135K for nine months, marking 12.3% increase versus prior year, driven by higher volumes.
Q3 Profitability Improvement Q3 Net Income $3,529K, up from $2,976K; Gross margin expanded significantly to 28.7% for the quarter.
Investment Sale Realized Recognized $3,407K gain from Simple Mills equity investment liquidation during the nine months ended September 30, 2025.
Strong Cash Position Ending cash balance $22,990K, showing increase from $20,558K at December 31, 2024, supporting liquidity.

Risk Factors

G&A Expense Spike G&A rose to $15,566K (NME) due to approximately $4,300K professional fees related to unsolicited purchase proposal.
Operating Cash Flow Decline Operating cash flow decreased to $10,681K (NME) from $15,541K primarily due to lower cash earnings reported.
Macroeconomic Uncertainty Monitoring Monitoring macroeconomic uncertainty due to inflation and trade policies potentially increasing supply chain complexity and costs.
Tax Rate Volatility Risk Effective tax rate changes driven by non-deductible officer and stock-based compensation expenses impacting income tax provisions.

Outlook

Major Facility Investment Estimating $45,000K capital spending for Waukesha facility modernization, targeting completion during fourth fiscal quarter 2026.
Organic Milk Supply Secured Purchased 402 cows for $1,335K to secure future organic milk supply via new agreements commencing December 1, 2025.
Credit Facility Available $25,000K available under Revolving Credit Facility; management expects sufficient liquidity for working capital needs.
New Tax Law Assessment New OBBBA tax law enacted July 2025, but currently not expected to materially impact estimated annual effective tax rate.

Peer Comparison

Revenue (TTM)

Dingdong (Cayman) LimitedDDL
$3.33B
+8.4%
B&G Foods, Inc.BGS
$1.84B
-6.0%
Westrock Coffee CompanyWEST
$1.08B
+28.9%

Gross Margin (Latest Quarter)

USANA Health Sciences, Inc.USNA
73.4%
-6.9pp
Vasta Platform LimitedVSTA
67.9%
+4.8pp
Lifeway Foods, Inc.LWAY
30.3%
+4.6pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
DDL$604.52M15.031.2%35.6%
MAMA$600.04M125.714.3%9.9%
WEST$453.14M-4.8-28.6%50.8%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
6.8%
Steady Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
50%
Cash Flow Needs Attention

Research & Insights

Next earnings:Mar 12, 2026
|
EPS:-
|
Revenue:-
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 12, 2025|
    Revenue: $57.14M+24.0%
    |
    EPS: $0.23+15.0%
    Miss

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 12, 2025|
    Revenue: $53.90M+9.7%
    |
    EPS: $0.28+7.7%
    Beat

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 13, 2025|
    Revenue: $46.09M+3.3%
    |
    EPS: $0.24+41.2%
    Meet

  • Form 10-K/A - FY 2024

    Period End: Dec 31, 2024|Filed: Apr 29, 2025|
    Revenue: $186.82M+16.7%
    |
    EPS: $0.61-21.8%
    Beat

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 14, 2025|Refer to amended data

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 14, 2024|
    Revenue: $46.10M+12.7%
    |
    EPS: $0.20-13.0%
    Miss

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 13, 2024|
    Revenue: $49.16M+25.3%
    |
    EPS: $0.26+18.2%
    Beat

  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 14, 2024|
    Revenue: $44.63M+17.8%
    |
    EPS: $0.17+199.8%
    Miss